RDY: Dr. Reddy's Laboratories Limited
Performance
Watchlist
Select an item
Summary
RDY at a glance
RDY returned +12.61% over the past year and +4.48% a year over five years. Its worst drop in that year was -26.01%, smaller than 67% of stocks on Redstone, and its Sharpe ratio of 0.44 beats 47% of stocks on Redstone. It yields 0.55%.
Current Drawdown
-1.45%
Rolling Volatility
22.95%
Dividends
RDY dividends
Yield
0.55%
Paid, past year
$0.08
Pays
Yearly
Growth a year
-2.9%
Per share, by year
Yearly return over 5 years
RDY paid $0.08 a share over the past year, once a year. Its yearly rate fell from $0.10 in 2023 to $0.09 in 2025, 2.9% a year. With dividends reinvested it returned +4.48% a year over five years, against +3.48% on price alone.
›All 7 payments since Jul 8, 2022
- Jul 24, 2026$0.0834
- Jul 25, 2025$0.0915
- Jul 30, 2024$0.0952
- Jul 28, 2023$0.0965
- Jul 7, 2023$0.0976
- Aug 1, 2022$0.0757
- Jul 8, 2022$0.0774
Metrics
Risk Indicators
Profile
About RDY
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr.
- Sector
- Health Care
- Market cap
- $12.5B
- Listed
- Apr 2001
- Employees
- 27,527
- Website
- drreddys.com
Comparisons